Linking Smoking, Coffee, Urate, and Parkinson’s Disease – A Role for Gut Microbiota?
Open accessThe DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Abstract
While the etiology and pathogenesis of Parkinson’s disease (PD) is still obscure, there is evidence for lifestyle factors influencing disease risk. Best established are the inverse associations with smoking and coffee consumption. In other contexts there is evidence that health effects of lifestyle factors may depend on gut microbiome composition. Considering the gastrointestinal involvement in PD, it was recently speculated, that the associations between smoking, coffee, and PD risk could be mediated by gut microbiota. Here we review such a possible mediatory role of gut microbiota taking into account recent findings on microbiome composition in PD and extending the scope also to urate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent analyses reveal that early constipation and gastrointestinal complaints are seen in 80% of PD patients [23, 24].”
From The gut–brain axis in early Parkinson’s disease: from prodrome to prevention (2025) · cites this paper as [23]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Smoking and caffeine have been shown to be protective against PD [23, 188].”
From The gut–brain axis in early Parkinson’s disease: from prodrome to prevention (2025) · cites this paper as [23]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“when “brain–gut axis” and “coffee” are combined as keywords in Pubmed, only three papers are retrieved (as of 29th November 2020), and two of them lead with the relationship of coffee with PD (see below) [197,198].”
From Effects of Coffee and Its Components on the Gastrointestinal Tract and the Brain–Gut Axis (2020) · cites this paper as [198]
In the citing paper
“These effects are unlikely to be mediated by caffeine; instead, an indirect action on the colon mediated by neural mechanisms or gastrointestinal hormones has been suspected [108].”
From Effects of Coffee on the Gastro-Intestinal Tract: A Narrative Review and Literature Update (2022) · cites this paper as [108]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624 · cited 1×
“The human gut is home to 1-2 kg of bacteria, contains 10-times more microbial cells than human cells and these microbes carry approximately 100–200times more protein coding genes than the human genome [23].”
BackgroundDiversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Host-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760 · cited 1×
“Gut microbiota influence the immune system and the absorption of nutrients, vitamins, medications, and toxic compounds [24–28].”
BackgroundMind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572
The gut microbiota--masters of host development and physiology
Sommer, F., & Bäckhed, F. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2974 · Cited by 3,681
Normal gut microbiota modulates brain development and behavior
Heijtz, R. D., Wang, S., Anuar, F., Qian, Y., Björkholm, B., Samuelsson, A., Hibberd, M. L., Forssberg, H., & Pettersson, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010529108 · Cited by 3,228
Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis
Scher, J. U., Sczesnak, A., Longman, R. S., Segata, N., Ubeda, C., Bielski, C., Rostron, T., Cerundolo, V., Pamer, E. G., Abramson, S. B., et al. (2013) · eLife · doi:10.7554/elife.01202 · Cited by 2,047
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968
Self-citationBercik, P., Denou, E., Collins, J., Jackson, W., Lu, J., Jury, J., Deng, Y., Blennerhassett, P., Macri, J., McCoy, K. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.052 · Cited by 1,748 · cited 1×
“There is an intense bidirectional interaction between gut microbiota and the nervous system influencing brain activity, behavior, as well as levels of neurotransmitter receptors and neurotrophic factors [30–34].”
BackgroundMicrobial co-occurrence relationships in the human microbiome
Faust, K., Sathirapongsasuti, J. F., Izard, J., Segata, N., Gevers, D., Raes, J., & Huttenhower, C. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002606 · Cited by 1,527 · cited 8×
“is inversely associated with that of Bacteroides [63].”
BackgroundInfluential
Cited by
The Emerging Evidence of the Parkinson Pandemic
Dorsey, E. R., Sherer, T., Okun, M. S., & Bloem, B. R. (2018) · Journal of Parkinson’s Disease · doi:10.3233/jpd-181474 · Cited by 1,977
Microbiota-Brain-Gut Axis and Neurodegenerative Diseases
Quigley, E. M. M. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0802-6 · Cited by 804
Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors
Klingelhoefer, L., & Reichmann, H. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.197 · Cited by 598
The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?
Houser, M. C., & Tansey, M. G. (2017) · npj Parkinson's Disease · doi:10.1038/s41531-016-0002-0 · Cited by 588
“Specifically, both smoking and drinking coffee are associated with significantly reduced incidence of PD, and it has been proposed that protective effects of tobacco and coffee may be mediated at least in part by modulation of the microbiota.(92,102) Some evidence now suggests that changes in certain bacterial taxa th…”
BackgroundResultChanges of colonic bacterial composition in Parkinson's disease and other neurodegenerative diseases
Gerhardt, S., & Mohajeri, M. H. (2018) · Nutrients · doi:10.3390/nu10060708 · Cited by 298
“Three studies found a significant reduction of Prevotellaceae family [32,43] or the genus Prevotella [34,39].”
BackgroundThe Concept of Prodromal Parkinson’s Disease
Mahlknecht, P., Seppi, K., & Poewe, W. (2015) · Journal of Parkinson's Disease · doi:10.3233/jpd-150685 · Cited by 288
Premotor, nonmotor and motor symptoms of Parkinson's Disease: A new clinical state of the art
Leite Silva, A. B. R., Gonçalves de Oliveira, R. W., Diógenes, G. P., de Castro Aguiar, M. F., Sallem, C. C., Lima, M. P. P., de Albuquerque Filho, L. B., Peixoto de Medeiros, S. D., Penido de Mendonça, L. L., de Santiago Filho, P. C., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101834 · Cited by 251
Recent advances and perspectives of metabolomics-based investigations in Parkinson’s disease
Shao, Y., & Le, W. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0304-2 · Cited by 238
Gut microbiota: Implications in Parkinson's disease
Parashar, A., & Udayabanu, M. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.02.002 · Cited by 230
The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review
Klann, E. M., Dissanayake, U., Gurrala, A., Farrer, M., Shukla, A. W., Ramirez-Zamora, A., Mai, V., & Vedam-Mai, V. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.782082 · Cited by 182
Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease
Zhu, M., Liu, X., Ye, Y., Yan, X., Cheng, Y., Zhao, L., Chen, F., & Ling, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.937555 · Cited by 177
Caffeine and Parkinson’s Disease: Multiple Benefits and Emerging Mechanisms
Ren, X., & Chen, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.602697 · Cited by 178
Parkinson’s Disease and the Gastrointestinal Microbiome
Lubomski, M., Tan, A. H., Lim, S.-Y., Holmes, A. J., Davis, R. L., & Sue, C. M. (2020) · Journal of Neurology · doi:10.1007/s00415-019-09320-1 · Cited by 172
Probiotics for Parkinson’s Disease
Gazerani, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174121 · Cited by 151
The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease
Yang, D., Zhao, D., Ali Shah, S. Z., Wu, W., Lai, M., Zhang, X., Li, J., Guan, Z., Zhao, H., Li, W., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01155 · Cited by 162
Effects of Coffee on the Gastro-Intestinal Tract: A Narrative Review and Literature Update
Nehlig, A. (2022) · Nutrients · doi:10.3390/nu14020399 · Cited by 158
Diet in Parkinson’s Disease: Critical Role for the Microbiome
Jackson, A., Forsyth, C. B., Shaikh, M., Voigt, R. M., Engen, P. A., Ramirez, V., & Keshavarzian, A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01245 · Cited by 145
Effects of Coffee and Its Components on the Gastrointestinal Tract and the Brain–Gut Axis
Iriondo-DeHond, A., Uranga, J. A., del Castillo, M. D., & Abalo, R. (2020) · Nutrients · doi:10.3390/nu13010088 · Cited by 126
“Interestingly, when “brain–gut axis” and “coffee” are combined as keywords in Pubmed, only three papers are retrieved (as of 29th November 2020), and two of them lead with the relationship of coffee with PD (see below) [197,198].”
BackgroundThe gut microbiome in Parkinson's disease: A culprit or a bystander?
(2020) · Progress in Brain Research · doi:10.1016/bs.pbr.2020.01.004 · Cited by 103
Diagnostic biomarkers for Parkinson’s disease at a glance: where are we?
Cova, I., & Priori, A. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1910-4 · Cited by 102
Lavefve, L., Marasini, D. N., & Carbonero, F. G. (2018) · Advances in food and nutrition research · doi:10.1016/bs.afnr.2018.09.001 · Cited by 93
Air pollution and Parkinson’s disease – evidence and future directions
Palacios, N. (2017) · Reviews on Environmental Health · doi:10.1515/reveh-2017-0009 · Cited by 83
How strong is the evidence that Parkinson's disease is a prion disorder?
Brundin, P., Ma, J., & Kordower, J. H. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000349 · Cited by 73
Tosato, M., & Marco, V. D. (2019) · Biomolecules · doi:10.3390/biom9070269 · Cited by 78
The Impact of Smoking on Microbiota: A Narrative Review
Cicchinelli, S., Rosa, F., Manca, F., Zanza, C., Ojetti, V., Covino, M., Candelli, M., Gasbarrini, A., Franceschi, F., & Piccioni, A. (2023) · Biomedicines · doi:10.3390/biomedicines11041144 · Cited by 66
Sex-dependent associations between addiction-related behaviors and the microbiome in outbred rats
Peterson, V. L., Richards, J. B., Meyer, P., Cabrera‐Rubio, R., Tripi, J. A., King, C. P., Polesskaya, O., Baud, A., Chitre, A. S., Bastiaanssen, T. F. S., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102769 · Cited by 65
Kia, D. A., Noyce, A. J., White, J., Speed, D., Nicolas, A., collaborators, I., Burgess, S., Lawlor, D. A., Smith, G. D., Singleton, A., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25294 · Cited by 62
The Gut and Nonmotor Symptoms in Parkinson's Disease
Klingelhoefer, L., & Reichmann, H. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.05.027 · Cited by 55
Gastric emptying in Parkinson's disease – A mini-review
Knudsen, K., Szwebs, M., Hansen, A. K., & Borghammer, P. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.06.003 · Cited by 49
Clearing the Smoke: What Protects Smokers from Parkinson's Disease?
Rose, K. N., Schwarzschild, M. A., & Gomperts, S. N. (2024) · Movement Disorders · doi:10.1002/mds.29707 · Cited by 51
Early life adversity predicts brain-gut alterations associated with increased stress and mood
Coley, E. J. L., Mayer, E. A., Osadchiy, V., Chen, Z., Subramanyam, V., Zhang, Y., Hsiao, E. Y., Gao, K., Bhatt, R. R., Dong, T. S., et al. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100348 · Cited by 51
He, S., Zhong, S., Liu, G., & Yang, J. (2020) · Neurodegenerative Diseases · doi:10.1159/000511083 · Cited by 45
The gut–brain axis in early Parkinson’s disease: from prodrome to prevention
Oliver, P. J., Civitelli, L., & Hu, M. T. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13138-5 · Cited by 42
“Recent analyses reveal that early constipation and gastrointestinal complaints are seen in 80% of PD patients [23, 24].”
Transdermal Nicotine Treatment and Progression of Early Parkinson’s Disease
Oertel, W. H., Müller, H., Unger, M. M., Schade‐Brittinger, C., Balthasar, K., Articus, K., Brinkman, M., Venuto, C. S., Tracik, F. M., Eberling, J. L., et al. (2023) · NEJM Evidence · doi:10.1056/evidoa2200311 · Cited by 36
Good bacteria, oxidative stress and neurological disorders: Possible therapeutical considerations
Soheili, M., Alinaghipour, A., & Salami, M. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120605 · Cited by 36
Elbaz, A. (2016) · Revue Neurologique · doi:10.1016/j.neurol.2016.07.001 · Cited by 34
Can Microbiota Research Change Our Understanding of Neurodegenerative diseases?
Scheperjans, F. (2016) · Neurodegenerative Disease Management · doi:10.2217/nmt-2015-0012 · Cited by 34
Self-citationYao, N., Yang, Y., Li, X., Wang, Y., Guo, R., Wang, X., Li, J., Xie, Z., Li, B., & Cui, W. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.906511 · Cited by 31
Schlossmacher, M. G., Tomlinson, J. J., dos Santos, G. M., Shutinoski, B., Brown, E. G., Manuel, D. G., & Mestre, T. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13476 · Cited by 32
Hull, A. J., Atilano, M. L., Gergi, L., & Kinghorn, K. J. (2024) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0381 · Cited by 30
Song, S., Liu, J., Zhang, F., & Hong, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-72202-4 · Cited by 27
Koros, C., Simitsi, A., Papagiannakis, N., Bougea, A. M., Prentakis, A. G., Papadimitriou, D. A., Pachi, I., Beratis, I., Stanitsa, E., Angelopoulou, E., et al. (2023) · Journal of Parkinson s Disease · doi:10.3233/jpd-230007 · Cited by 25
Dietary phytochemicals that influence gut microbiota: Roles and actions as anti-Alzheimer agents
Wang, Y., Lim, Y. Y., He, Z., Wong, W., & Lai, W. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1882381 · Cited by 26
Drobny, A., Ngo, P. A., Neurath, M. F., Zunke, F., & López-Posadas, R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.655123 · Cited by 24
Parkinson's disease: Are gut microbes involved?
Omotosho, A. O., Tajudeen, Y. A., Oladipo, H. J., Yusuff, S. I., Abdulkadir, M., Muili, A. O., Egbewande, O. M., Yusuf, R. O., Faniran, Z. O., Afolabi, A. O., et al. (2023) · Brain and Behavior · doi:10.1002/brb3.3130 · Cited by 24
Smoking, coffee intake, and Parkinson’s disease: Potential protective mechanisms and components
Hong, S. W., Page, R., & Truman, P. (2024) · NeuroToxicology · doi:10.1016/j.neuro.2024.12.003 · Cited by 24
Association between physical fitness, cardiovascular risk factors, and Parkinson's disease
Müller, J., & MYERS, J. N. (2018) · European Journal of Preventive Cardiology · doi:10.1177/2047487318771168 · Cited by 24
Significance of nicotine and nicotinic acetylcholine receptors in Parkinson’s disease
Xia, L., Li, Q., Pu, M., Dong, H., & Zhang, Q. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1535310 · Cited by 23
Dietary nicotine intake and risk of Parkinson disease: a prospective study
Ma, C., Molsberry, S. A., Li, Y., Schwarzschild, M. A., Ascherio, A., & Gao, X. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa186 · Cited by 23
Coffee and Parkinson's disease
Asuku, A. O., Ayinla, M. T., Olajide, T. S., Oyerinde, T. O., Yusuf, J. A., Bayo-Olugbami, A. A., & Fajemidagba, G. A. (2024) · Progress in brain research · doi:10.1016/bs.pbr.2024.06.001 · Cited by 21
Shared Metabolic Profile of Caffeine in Parkinsonian Disorders
Takeshige‐Amano, H., Saiki, S., Fujimaki, M., Ueno, S., Li, Y., Hatano, T., Ishikawa, K., Oji, Y., Mori, A., Okuzumi, A., et al. (2020) · Movement Disorders · doi:10.1002/mds.28068 · Cited by 20
Yang, J., Deng, Y., Cai, Y., Liu, Y., Peng, L., Luo, Z., & Li, D. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1048565 · Cited by 18
Farag, M. A., von Bergen�, M., Saleh, B. M., Homsi, M. N., & El-Al, M. S. A. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.11.004 · Cited by 18
Modifiable Risk Factors for Dementia: The Role of Gut Microbiota
Cabrera, C., Vicens, P., & Torrente, M. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666211215152411 · Cited by 15
Non-Motor Correlates of Smoking Habits in de Novo Parkinson’s Disease
Moccia, M., Mollenhauer, B., Erro, R., Picillo, M., Palladino, R., & Barone, P. (2015) · Journal of Parkinson s Disease · doi:10.3233/jpd-150639 · Cited by 13
The Role of Gut Microbiota in Neuromyelitis Optica Spectrum Disorder
Yao, S., Yang, X., Cen, L., & Tan, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063179 · Cited by 13
Chen, C., Chiu, J.-Y., Tan, A. H., Toh, T. S., Lim, S., Tan, E., Pettersson, S., Hsu, C., Liou, J., Wu, M.-S., et al. (2025) · Neurology · doi:10.1212/wnl.0000000000213592 · Cited by 13
Lu, E., Sarkar, S., Raymick, J. B., Paule, M. G., & Gu, Q. (2017) · Brain Research · doi:10.1016/j.brainres.2017.11.014 · Cited by 12
Multiple catechols in human plasma after drinking caffeinated or decaffeinated coffee
Goldstein, D. S., Sullivan, P., Corrales, A., Isonaka, R., Gelsomino, J., Cherup, J., Castillo, G., & Holmes, C. S. (2021) · Journal of Chromatography B · doi:10.1016/j.jchromb.2021.122988 · Cited by 10
Sequestration of Inflammation in Parkinson’s Disease via Stem Cell Therapy
Gordon, J., Lockard, G., Monsour, M., Alayli, A., Choudhary, H., & Borlongan, C. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710138 · Cited by 10
Sood, R., Sanjay, S., Kang, S.-U., Yoon, N. Y., & Lee, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312733 · Cited by 9
Disease mechanisms as subtypes: Microbiome
Bonvegna, S., & Cilia, R. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85555-6.00006-0 · Cited by 8
Effects of Coffee on Intestinal Microbiota, Immunity, and Disease
Preda, M., Popa, M. I., Mihai, M. M., Oţelea, T. C., & Holban, A. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815864-7.00012-x · Cited by 7
Prevotella copri -mediated caffeine metabolism involves ferroptosis of osteoblasts in osteoarthritis
Li, F., Wen, X., Xue, P., Xu, H., Wu, P., Xu, Z., Wang, X., & Pi, G. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.01575-24 · Cited by 6
The epidemiology of animal bite, scratch, and other potential rabies exposures, Louisiana.
Balsamo, G. A., Ratard, R. C., & Claudet, A. L. (2009) · PubMed · Cited by 6
Domínguez, R. O., Marschoff, E. R., Oudkerk, L. M., Angulo, L. E. D. L. O., Pérez, S. V., Bianchi, G. A., Repetto, M. G., & Serra, J. A. (2022) · Current Aging Science · doi:10.2174/1874609815666220118104234 · Cited by 4
Min, W. Z., & Tang, Z. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112503 · Cited by 3
Recent Insights on the Prospective role of Phytocompounds in Modulating Gut-Brain Axis
Kumari, N., Anand, S., Shah, K., & Chauhan, N. S. (2024) · Current Pharmacology Reports · doi:10.1007/s40495-024-00364-0 · Cited by 3
Yang, X., Yan, H., Chen, Y., & Rui, G. (2025) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s512855 · Cited by 3
Fecal Microbiota Transplants as a Treatment Option for Parkinson’s Disease
Flameling, I. A., & Rijkers, G. T. (2018) · IntechOpen eBooks · doi:10.5772/intechopen.78666 · Cited by 3
NUTRITION MANAGEMENT FOR COGNITIVE DISORDERS AND DEMENTIA (OVERVIEW)
Николаевна, Б. Л., Yakushin, M. A., & Karpova, O. V. (2025) · Problems of Social Hygiene Public Health and History of Medicine · doi:10.32687/0869-866x-2025-33-3-494-501 · Cited by 3
A Novel Therapeutic Strategy for Parkinson's Disease based on the Gut Microbiota: A Rreview Article
Kardan, R., Nazari, M., Hemmati, J., Ahmadi, A., & Ashab, M. (2024) · Scientific Journal of Kurdistan University of Medical Sciences · doi:10.61186/sjku.29.3.11 · Cited by 2
Langley, M. R. (2017) · Iowa State University Digital Repository (Iowa State University) · Cited by 2
Metabolomic Biomarkers in Parkinson’s Disease
Shao, Y., Xu, X., Wang, N., Xu, G., & Le, W. (2021) · Neuromethods · doi:10.1007/978-1-0716-1712-0_8 · Cited by 2
Yavuz, N. C., Nayyar, K., Pappafava, F., Praveen, J., Nair, A. N., Bora, M. U., Aldoohan, F., Hudli, A. R. M. Y., Siddenki, Y. R., Nazir, S., et al. (2025) · Cureus · doi:10.7759/cureus.90055 · Cited by 1
The Gut Microbiome in Neurodegenerative Disorders
Euers, L. A., & Quigley, E. M. M. (2020) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190931544.013.11 · Cited by 1
Does Nicotine from Passive Smoking and Foods Protect Against Parkinson’s Disease?
Faramarzi, E., Fathalizadeh, A., Sanaie, S., Mirghafourvand, M., Reyhanifard, A., Rahnemayan, S., & Mahmoodpoor, A. (2022) · Current Nutrition & Food Science · doi:10.2174/1573401318666220401112508 · Cited by 1
What Are the Effects of Coffee at the Different Levels of the Digestive Tract?
Nehlig, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-93459-9_12 · Cited by 1
Characterization of the Phosphomimetic Mutant Y39E of a-Synuclein
Böffinger, N. M. (2024) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10640 · Cited by 1
Gut Microbiota in Brain diseases
Salami, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00040-1
Inicio y progresión de la enfermedad de parkinson: papel de la activación glial
Rodríguez-Chinchilla, T. (2020) · Communities in ADDI (Universidad del Pais Vasco)
Gut-Brain Interplay and Cognitive Degeneration
Krishnamoorthy, K., Rajagopal, P., & Jayaraman, S. (2024) · Springer eBooks · doi:10.1007/978-981-99-8803-7_4
Gut Microbiome Modulation of Innate Immunity in Neurodegenerative Diseases
Merchak, A. R., Menees, K. B., Bolen, M. L., & Tansey, M. G. (2024) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190931544.013.14
Efeitos da estimulação da medula espinhal dorsal na marcha em pacientes com doença de Parkinson
Carra, R. B. (2025) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2025.tde-29102025-163803
Campolongo, A. (2024) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Gonçalves, D. D. O. (2017) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Coley, E. J. L. (2024) · eScholarship (California Digital Library)
Wirkung von Koffein auf die IFN-γ Produktion in Th1-Zellen bei Patienten mit Rheumatoider Arthritis
Gloyer, L. (2025) · Kölner Universitäts PublikationsServer (Universität zu Köln)
Heme oxygenase-1 in the pathogenesis and diagnosis of idiopathic Parkinson disease
Cressatti, M. (2020) · eScholarship@McGill (McGill) · doi:10.82308/24723
Parkinson’s disease biomarkers: bridging the gap between diagnosis and treatment
Chakkarwar, V. A., & Kulkarni, Y. A. (2026) · Behavioural Brain Research · doi:10.1016/j.bbr.2026.116120
Etude physiopathologique de la diffusion de la maladie de parkinson au système nerveux autonome
Leclair‐Visonneau, L. (2017) · theses.fr (ABES) · doi:10.70675/6537e18cze1c8z4bd8zad04z73a63a9ae4fe
Nutritional Management in Cognitive Impairment and Dementia: A Literature Review
Yakushin, M. A., Karpova, O. V., Николаевна, Б. Л., & Sokolova, E. (2026) · City Healthcare · doi:10.47619/2713-2617.zm.2026.v.7i3;125-135
Организация питания при когнитивных расстройствах и деменции (обзор)
Николаевна, Б. Л., А., Я. М., & В., К. О. (2025) · Problems of Social Hygiene Public Health and History of Medicine
Lin, J., & Zou, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1956619
Spithoven, J. (n.d.) · Murdoch University Research Portal
Metadata
- Authors
- Scheperjans, F., Pekkonen, E., Kaakkola, S., & Auvinen, P.
- Affiliations
- University of Helsinki (FI)
- Corresponding author
- Scheperjans, Filip
- Venue
- Journal of Parkinson’s Disease
- Publisher
- SAGE Publications
- Published
- 2015-06-01
- Volume
- 5
- Issue
- 2
- Pages
- 255-262
- ISSN
- 1877-7171 (ISSN-L)
- 1877-718X
- OpenAlex
- W1866784932
- Cited by
- 83
- References
- 78
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 11 · 2023: 5 · 2022: 10 · 2021: 7 · 2020: 9 · 2019: 8 · 2018: 8 · 2017: 7 · 2016: 4 · 2015: 3
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Parkinson s Disease (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
- Keywords
- Parkinson's disease, gut microbiota, smoking, coffee consumption, uric acid, lifestyle factors, disease risk, mediation, gastrointestinal involvement, microbiota composition
- MeSH terms
- Gastrointestinal Microbiome, Animals, Coffee, Humans, Parkinson Disease, Risk Factors, Smoking, Uric Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.